U.K. Healthtech Stock News

If you are wondering whether Rio Tinto Group is still good value after its recent run, this article will walk through what the current share price might be implying about the company. Rio Tinto’s share price sits at £68.37, with returns of 3.7% decline over 7 days, 0.1% decline over 30 days, 14.2% year to date, 51.0% over 1 year, 45.7% over 3 years and 80.4% over 5 years. This provides plenty of data points for a closer look at value. Recent news around Rio Tinto has focused on its role as a...

Shell (LSE:SHEL) has been on many investors’ radar after its recent share price move, with the stock showing double digit returns over the past month and over the past three months. See our latest analysis for Shell. That recent surge sits within a stronger run, with a 14.63% 1 month share price return and a 17.40% 3 month share price return, while the 1 year total shareholder return of 29.57% and 5 year total shareholder return of 154.31% suggest momentum has been building over time. If...

If you are wondering whether BAE Systems at £22.49 is still reasonable value after a strong run, this article will walk through what the current price actually reflects. The stock has recorded returns of 1.3% over 7 days, 19.7% over 30 days, 28.2% year to date and 45.5% over 1 year, with a very large 3 year return and a 5 year return comfortably above 7x, which naturally raises questions about what is already priced in. Recent coverage has focused on BAE Systems' role as a major defence...

BP (LSE:BP) and JERA Nex have signed a master services agreement with Interocean Marine Services to support global offshore wind activities. The partnership focuses on marine consultancy and operational support for offshore wind projects in multiple regions. This agreement adds a new element to BP's renewables and offshore wind plans alongside its existing energy transition goals. For you as an investor, this move adds more detail to BP's push into renewables alongside its traditional oil...

GSK has licensed global rights to its late stage liver disease drug linerixibat to Alfasigma in a major transaction. The deal covers linerixibat for cholestatic pruritus in primary biliary cholangitis, with GSK receiving upfront, milestone and royalty payments. The agreement comes shortly before an expected FDA decision on linerixibat and allows GSK to reallocate resources across its pipeline. LSE:GSK is making this move at a time when its share price stands at £20.64, with a return of...

Health Canada approves Koselugo (selumetinib) for adults with neurofibromatosis type 1, expanding AstraZeneca’s rare disease reach in Canada. The US FDA grants Priority Review to ENHERTU for early stage HER2 positive breast cancer, targeting a new setting in AstraZeneca’s oncology franchise. Both decisions mark fresh regulatory momentum for AstraZeneca (LSE:AZN) across rare disease and oncology portfolios. For you as an investor, these updates add additional context to AstraZeneca’s mix of...

Lloyds Banking Group (LSE:LLOY) plans to expand commercial use of anonymised customer data. The bank is preparing a significant shift of its systems and records to cloud storage. Major automation is set to be introduced in compliance processes. The group intends to reduce IT costs and retire internal apps and data centres. Lloyds Banking Group, one of the largest retail and commercial banks in the UK, is reshaping how it handles technology and data. The focus on anonymised data, cloud...

Shell has agreed to sell Jiffy Lube International and Premium Velocity Auto to Monomoy Capital Partners as part of a portfolio reshuffle. The company is also increasing its commitment to the Raízen joint venture, including capital support and potential moves toward majority control. These decisions reflect a refocus on core operations and key markets that Shell sees as central to its long term direction. For investors tracking LSE:SHEL, these announcements come at a time when the share...

Context for Pan African Resources Pan African Resources (LSE:PAF) has caught investor attention after a period of mixed short term share performance, including a 1 day gain and a weaker week, alongside stronger returns over the month and past 3 months. That recent share price pattern comes against a backdrop of £837.761 revenue and £241.349 net income, with both revenue and earnings showing annual growth, and a value score of 5 that may interest investors focused on company fundamentals. See...

Diageo (LSE:DGE) has closed its Crown Royal whisky plant in Amherstburg, Ontario earlier than planned, affecting over 200 employees. The shutdown was executed two days ahead of schedule and without advance notice to staff. At the same time, Diageo is rolling out new premium products, including Oban 15-Year Port Cask Finish and Johnnie Walker Black Cask. For you as an investor, this mix of plant closure and premium product launches underlines how Diageo earns its money from global spirits...

Why Rio Tinto Group stock is on investors’ radar Rio Tinto Group (LSE:RIO) has attracted attention after recent share price moves, with the stock showing a 1 day return of 1.69% and a 9.56% decline over the past week. Over the past month the shares show a 3.04% decline, while the past 3 months figure stands at 20.03%. Year to date, Rio Tinto Group’s total return is 10.84%, with a 44.51% total return over the past year. See our latest analysis for Rio Tinto Group. Recent share price weakness,...

Why BAE Systems (LSE:BA.) is on investors’ radar now BAE Systems (LSE:BA.) shares have moved sharply over the past year, with a 44.1% total return and gains across the past month and past 3 months, putting the defense group firmly in focus for investors. See our latest analysis for BAE Systems. BAE Systems’ recent move to a £22.14 share price follows a run of strong momentum, with a 30 day share price return of 18.11% and a 5 year total shareholder return of 410.96%. This suggests investors...

If you are wondering whether Glencore's current share price still offers value, you are not alone. This article is designed to walk you through the numbers clearly. Over the past week the stock recorded a 5.8% decline, while the 1 year return sits at 62% and the year to date return is 23%, so recent moves look quite different depending on your time frame. Recent news around Glencore has focused on its role as a global commodities and trading group and what that means for investor sentiment...

NatWest Group (LSE:NWG) has appointed Adeel Hyder as Managing Director of Business Banking. Hyder joins from Starling Bank, bringing experience in digital-first banking and SME services. The new role focuses on support for UK small and micro businesses through digital tools and specialist guidance. For you as an investor, this move sits at the intersection of traditional banking and increasingly digital business services. NatWest Group is a major UK bank with an established business banking...

HSBC U.K., part of HSBC Holdings (LSE:HSBA), announced a leadership reshuffle with Dame Clara Furse retiring as non executive chair. Dame Carolyn Fairbairn will assume the role of non executive chair, marking an unexpected change at the top of the U.K. business. The move has raised questions among investors about board oversight, long term priorities and how the U.K. arm fits within the wider group. For a bank the size of HSBC Holdings, with deep roots in global retail, commercial and...

Why GSK stock is on investors’ radar today GSK (LSE:GSK) has been drawing attention after a period of mixed share performance, with a 1 day return of 1.83% alongside a 7 day decline of 7.41% and a modest month fall of 2.02%. Over longer periods, the stock shows a 12.9% gain in the past 3 months, 11.27% year to date and a 38.25% total return over 1 year, with 3 year and 5 year total returns of 64.24% and 97.99% respectively. See our latest analysis for GSK. At a share price of £20.38, GSK has...

Barclays share performance and recent context Barclays (LSE:BARC) has drawn investor attention after a mixed run in its share performance, with the stock showing a negative move over the past month but a positive total return over the past year. For context, the shares show a 17% decline over the past month and a 4% decline over the past 3 months. The 1 year total return figure sits at 38%. That backdrop frames how some investors are thinking about the bank’s current valuation and its recent...

British American Tobacco (LSE:BATS) is facing a new lawsuit in London from shareholders. The claim focuses on alleged nondisclosure of breaches of U.S. sanctions linked to business dealings in North Korea. Shareholders allege they were not fully informed about material regulatory issues following a prior sanctions settlement. The case raises questions about the company’s governance, disclosure practices, and potential legal liabilities. British American Tobacco, the multinational tobacco...

Why Unilever is on investors’ radar today Unilever (LSE:ULVR) has been drawing attention after recent share price moves, with the stock showing mixed short term returns but positive performance over the past year and multi year period. For context, the shares are around £51.15, with a 1 day return of about 0.4% decline and a 7 day return of roughly 5.3% decline, while the month and past 3 months show gains of 2.5% and 2.7% respectively. See our latest analysis for Unilever. Recent share price...

If you are wondering whether British American Tobacco is still attractively priced after a strong run, this article walks through what the current share price might be implying about long term value. The stock has returned 57.1% over the past year and 8.1% year to date, with a recent 2.1% gain over 30 days despite a 1.9% pullback in the last week, which may signal changing views on both its potential and its risks. Recent headlines around British American Tobacco have focused on the broader...

Recent share performance and business snapshot AstraZeneca (LSE:AZN) has seen mixed short term returns, with a 2.1% decline over the past day and a 2.6% pullback over the past week, while the share price is higher over the past month. Over the past 3 months and year to date, the stock has posted positive total returns, alongside a 1 year total return of 25.9%. Over 3 and 5 years, total returns are higher again, reflecting a longer period of shareholder gains. The company reports annual...

Fresnillo (LSE:FRES) reported record financial performance for the year, with revenues and profits at all time highs. The company achieved this result despite declines in silver and gold production. Fresnillo also paid its highest dividend since its listing, supported by elevated precious metal prices. Fresnillo is a major precious metals producer, with a core focus on silver and gold. The latest results come at a time when precious metal prices have been elevated, which can have a strong...

Recent performance snapshot for BP (LSE:BP.) With no single headline event driving attention, BP (LSE:BP.) has still attracted interest after a period where the shares show a one-month return of 6.30% and a three-month return of 6.25%. See our latest analysis for BP. At a share price of £4.93, BP’s recent share price momentum, with a 7 day share price return of 4.63% and year to date share price return of 12.58%, sits alongside a 1 year total shareholder return of 27.94% and 5 year total...

Rio Tinto has approved the resumption of the Zulti South mineral sands project in South Africa, including a $473m investment. The company is also progressing work on primary gallium extraction in Quebec, supported by research partners and the Canadian government. Both projects are aimed at securing long term supplies of materials used in industrial applications and emerging technologies. Rio Tinto Group (LSE:RIO), trading at around £73.36, sits in the large cap mining space with returns of...